The Biostatistics Core provides expertise in statistical science to ensure scientific rigor in study design, statistical analysis, and interpretation of cancer research studies. The Biostatistics Core is grouped in the Cross Disciplinary Research Core Cluster which, in addition to the Biostatistics Core, includes the Pharmacology, Genomics, and Biobanking and Correlative Sciences Cores. Members of the Core have expertise in a wide range of scientific disciplines including design and analysis of clinical trials, observational studies, in vitro and in vivo studies, biomarker discovery and validation projects, bioinformatics projects in collaboration with the Genomics Core and metabolomics studies in collaboration with the Pharmacology Core. They collaborate with cancer center investigators in the planning phase of studies to ensure that their hypotheses are testable and that the data will be adequate to address the study questions. They provide expertise on data collection and management and devise analysis plans consistent with the study objectives. At the completion of the study they evaluate the data for conformity with the assumptions of the statistical tests, provide estimates of the endpoints with confidence intervals, develop appropriate statistical models, assess the adequacy of the models and prepare written reports to the investigator. The Biostatistics Core has an important role in cancer research at KCI. During the current grant period (12/1/2010 -- 11/30/2014), the Core's collaborative activities resulted in 121 clinical protocols and 263 new cancer research proposals submitted for peer reviewed, external funding. Of these, 178 were submitted to the NCI, 36 to the DOD, and 4 to the Susan G. Komen Foundation. In addition, Biostatistics Core members were co-authors on 87 publications in peer reviewed journals. Core biostatisticians collaborate with investigators from each of the KCI research programs and work with staff from other KCI cores. The Core maintains a variety of statistical applications including general-purpose statistical software, R, SAS and Stata/MP, as well as software for statistical power calculations including PASS and nQuery Advisor. The Core shares an Ingenuity Pathway Analysis (IPA) license with the Genomics Core. Application software resides on a high-performance, multi-processor Dell 820 server. Access to the server is restricted to members of the Biostatistics Core and authorized guests. For intensive computing projects, members of the Core use the WSU high-performance grid, four servers of which have been contributed to KCI, running under Linux, for the use of Core members. These computers are accessible to other authorized KCI members whose research requires high performance computing.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA022453-38
Application #
9836636
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
38
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Ravindra, Manasa; Wilson, Mike R; Tong, Nian et al. (2018) Fluorine-Substituted Pyrrolo[2,3- d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor ? and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis. J Med Chem 61:4228-4248
Kim, Seongho; Wong, Weng Kee (2018) Extended two-stage adaptive designs with three target responses for phase II clinical trials. Stat Methods Med Res 27:3628-3642
Beebe-Dimmer, Jennifer L; Albrecht, Terrance L; Baird, Tara E et al. (2018) The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A focus on outcomes after cancer in a racially-diverse patient population. Cancer Epidemiol Biomarkers Prev :
Ahmed, Zainab Sabry Othman; Li, Xin; Li, Feng et al. (2018) Computational and biochemical studies of isothiocyanates as inhibitors of proteasomal cysteine deubiquitinases in human cancer cells. J Cell Biochem 119:9006-9016
Desai, Pinkal; Wallace, Robert; Anderson, Matthew L et al. (2018) An analysis of the effect of statins on the risk of Non-Hodgkin's Lymphoma in the Women's Health Initiative cohort. Cancer Med 7:2121-2130
White, Donna L; Hoogeveen, Ron C; Chen, Liang et al. (2018) A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Cancer Med 7:2180-2191
Shaik, Asra N; Ruterbusch, Julie J; Abdulfatah, Eman et al. (2018) Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease. Breast Cancer Res 20:91
Farrell, Allison K; Slatcher, Richard B; Tobin, Erin T et al. (2018) Socioeconomic status, family negative emotional climate, and anti-inflammatory gene expression among youth with asthma. Psychoneuroendocrinology 91:62-67
Colacino, Justin A; Azizi, Ebrahim; Brooks, Michael D et al. (2018) Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling. Stem Cell Reports 10:1596-1609
Herroon, Mackenzie K; Rajagurubandara, Erandi; Diedrich, Jonathan D et al. (2018) Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and Survivin. Sci Rep 8:40

Showing the most recent 10 out of 826 publications